FDA, Barr to meet on “morning-after pill” status

	Tweet

U.S. health regulators will meet immediately with Barr Pharmaceuticals Inc. about the over-the-counter status of the Plan B contraceptive known as the “morning-after pill,” according to a report on cable network CNBC Monday.

News of the meeting comes just days ahead of a scheduled Senate committee confirmation hearing on the stalled nomination of Dr. Andrew von Eschenbach to run the U.S. Food and Drug Administration.

President George W. Bush nominated von Eschenbach as FDA commissioner in March, but two Senate Democrats have pledged to block his confirmation until the agency decides whether to approve Barr application for an over-the-counter “morning-after” contraceptive. 

Last year, then-FDA Commissioner Lester Crawford said the drug was safe for use in women 17 and older but indefinitely postponed a decision, citing concerns over how to enforce the age limit.

RELATED STORIES:
Low-dose Glaxo bird flu vaccine seen ready in 2007   OC’s Rogge sees threat in designer steroids   Ibuprofen curbs aspirin’s anti-clotting action   UK to rule Monday if Alzheimer’s drugs worth using   Osteoporosis: Breaking Bones Is Big Business   Key senator vows work on diet supplement bill   Tamiflu: Full reports from trials should be public and regulators respond to Tamiflu recommendations   Cholesterol drugs promising for multiple sclerosis   Xenical linked to kidney stone formation in rats   Study supports controversial blood-thinning drug   Elderly skip cholesterol and blood pressure drugs   Canada warns it cannot be the drugstore to U.S.

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]